Van der Meer JW - Search Results

1

Toll-like receptors as an escape mechanism from the host defense.

Netea MG, Van der Meer JW, Kullberg BJ. Netea MG, et al. Among authors: van der meer jw. Trends Microbiol. 2004 Nov;12(11):484-8. doi: 10.1016/j.tim.2004.09.004. Trends Microbiol. 2004. PMID: 15488388

2

Candida-specific interferon-gamma deficiency and toll-like receptor polymorphisms in patients with chronic mucocutaneous candidiasis.

van der Graaf CA, Netea MG, Drenth IP, te Morsche RH, van der Meer JW, Kullberg BJ. van der Graaf CA, et al. Among authors: van der meer jw. Neth J Med. 2003 Nov;61(11):365-9. Neth J Med. 2003. PMID: 14768719 Free article.

3

Recognition of fungal pathogens by Toll-like receptors.

Netea MG, Van der Graaf C, Van der Meer JW, Kullberg BJ. Netea MG, et al. Among authors: van der graaf c, van der meer jw. Eur J Clin Microbiol Infect Dis. 2004 Sep;23(9):672-6. doi: 10.1007/s10096-004-1192-7. Epub 2004 Aug 18. Eur J Clin Microbiol Infect Dis. 2004. PMID: 15322932 Review.

4

Role of the dual interaction of fungal pathogens with pattern recognition receptors in the activation and modulation of host defence.

Netea MG, Van der Meer JW, Kullberg BJ. Netea MG, et al. Among authors: van der meer jw. Clin Microbiol Infect. 2006 May;12(5):404-9. doi: 10.1111/j.1469-0691.2006.01388.x. Clin Microbiol Infect. 2006. PMID: 16643515 Free article. Review.

5

Recognition of pathogenic microorganisms by Toll-like receptors.

Netea MG, Van der Meer JW, Kullberg BJ. Netea MG, et al. Among authors: van der meer jw. Drugs Today (Barc). 2006 Mar;42 Suppl A:99-105. Drugs Today (Barc). 2006. PMID: 16683049 Review.

6

Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia.

Netea MG, Hijmans A, van Wissen S, Smilde TJ, Trip MD, Kullberg BJ, de Boo T, Van der Meer JW, Kastelein JJ, Stalenhoef AF. Netea MG, et al. Among authors: van wissen s, van der meer jw. Eur J Clin Invest. 2004 Feb;34(2):94-9. doi: 10.1111/j.1365-2362.2004.01303.x. Eur J Clin Invest. 2004. PMID: 14764071

7

Does the shape of lipid A determine the interaction of LPS with Toll-like receptors?

Netea MG, van Deuren M, Kullberg BJ, Cavaillon JM, Van der Meer JW. Netea MG, et al. Among authors: van der meer jw, van deuren m. Trends Immunol. 2002 Mar;23(3):135-9. doi: 10.1016/s1471-4906(01)02169-x. Trends Immunol. 2002. PMID: 11864841

8

Non-LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways.

Netea MG, Kullberg BJ, Galama JM, Stalenhoef AF, Dinarello CA, Van der Meer JW. Netea MG, et al. Among authors: van der meer jw. Eur J Immunol. 2002 Apr;32(4):1188-95. doi: 10.1002/1521-4141(200204)32:4<1188::AID-IMMU1188>3.0.CO;2-A. Eur J Immunol. 2002. PMID: 11932927 Free article.

9

The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis.

Netea MG, Van Der Graaf CA, Vonk AG, Verschueren I, Van Der Meer JW, Kullberg BJ. Netea MG, et al. Among authors: van der graaf ca, van der meer jw. J Infect Dis. 2002 May 15;185(10):1483-9. doi: 10.1086/340511. Epub 2002 Apr 30. J Infect Dis. 2002. PMID: 11992285

10

Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing?

Netea MG, van der Meer JW, van Deuren M, Kullberg BJ. Netea MG, et al. Among authors: van der meer jw, van deuren m. Trends Immunol. 2003 May;24(5):254-8. doi: 10.1016/s1471-4906(03)00079-6. Trends Immunol. 2003. PMID: 12738419 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,023 results

Search Page

Filters